Receptor tyrosine kinase ROR1 ameliorates Aβ1-42 induced cytoskeletal instability and is regulated by the miR146a-NEAT1 nexus in Alzheimer's disease.
Kaushik ChandaNihar Ranjan JanaDebashis MukhopadhyayPublished in: Scientific reports (2021)
Alzheimer's disease (AD) involves severe cytoskeletal degradation and microtubule disruption. Here, we studied the altered dynamics of ROR1, a Receptor Tyrosine Kinase (RTK), and how it could counter these abnormalities. We found that in an Aβ1-42 treated cell model of AD, ROR1 was significantly decreased. Over expressed ROR1 led to the abrogation of cytoskeletal protein degradation, even in the presence of Aβ1-42, preserved the actin network, altered actin dynamics and promoted neuritogenesis. Bioinformatically predicted miRNAs hsa-miR-146a and 34a were strongly up regulated in the cell model and their over expression repressed ROR1. LncRNA NEAT1, an interactor of these miRNAs, was elevated in mice AD brain and cell model concordantly. RNA Immunoprecipitation confirmed a physical interaction between the miRNAs and NEAT1. Intuitively, a transient knock down of NEAT1 increased their levels. To our knowledge, this is the first instance which implicates ROR1 in AD and proposes its role in preserving the cytoskeleton. The signalling modalities are uniquely analyzed from the regulatory perspectives with miR-146a and miR-34a repressing ROR1 and in turn getting regulated by NEAT1.
Keyphrases
- tyrosine kinase
- long non coding rna
- cell proliferation
- long noncoding rna
- epidermal growth factor receptor
- single cell
- cell therapy
- physical activity
- transcription factor
- binding protein
- cognitive decline
- mouse model
- mental health
- stem cells
- mesenchymal stem cells
- multiple sclerosis
- quantum dots
- bone marrow
- resting state
- diabetic rats
- fluorescent probe
- high glucose
- nucleic acid